The announcement of a Virtual Analyst & Investor Day with a focus on Glioblastoma Multiforme, a critical area in cancer treatment, is likely to attract attention from investors and analysts. This could lead to increased interest in CNSP's stock, as the event highlights the company's commitment to addressing a significant medical challenge.